ClinicalTrials.gov
public full text
Public Domain
Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System
The purpose of this study is to see if adding a drug called Regadenoson to the EVLP circulation reservoir during perfusion of marginal donor lungs will help increase the likelihood that the donor lungs will become usable for transplantation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility#1045274
- Lung Transplant Specimen Repository and Data Registry Protocol#1072849
- Xenon MRI Pulm Hypertension#1339987
- Nitric Oxide in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO)#1371105
- Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors#28498
Record · ID 1185974
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive